MDT

98.5

+2.11%↑

A

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

MDT

98.5

+2.11%↑

A

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

MDT

98.5

+2.11%↑

A

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

MDT

98.5

+2.11%↑

A

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

MDT

98.5

+2.11%↑

A

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

Search

Smith & Nephew PLC ADR

Закрыт

32.92 3.42

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

31.89

Макс.

33.09

Ключевые показатели

By Trading Economics

Доход

296M

Продажи

3B

P/E

Средняя по отрасли

30.342

90.831

Дивидендная доходность

2.26

Рентабельность продаж

9.895

Сотрудники

17,000

EBITDA

723M

Рекомендации

By TipRanks

Рекомендации

Нейтрально

Прогноз на 12 месяцев

+6.15% upside

Дивиденды

By Dow Jones

Дивидендная доходность

Средняя по отрасли

2.26%

2.20%

Рыночная статистика

By TradingEconomics

Рыночная капитализация

15B

Предыдущая цена открытия

29.5

Предыдущая цена закрытия

32.92

Техническая оценка

By Trading Central

Уверенность

Bullish Evidence

Smith & Nephew PLC ADR График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

14 янв. 2026 г., 22:41 UTC

Приобретения, слияния, поглощения

Canadian Natural Resources, Tourmaline File Deal Notice With Antitrust Regulator

15 янв. 2026 г., 00:00 UTC

Отчет

Welcome to Greenland, an Economy Reliant on Subsidies and Shrimp -- WSJ

14 янв. 2026 г., 23:47 UTC

Обсуждения рынка

Oil Slips After Trump Appears to Tilt Away From Military Action in Iran -- Market Talk

14 янв. 2026 г., 23:44 UTC

Обсуждения рынка

Nikkei May Decline After Hitting Record Highs; Election in Focus -- Market Talk

14 янв. 2026 г., 23:39 UTC

Обсуждения рынка

ANZ's New Bull Still Sees Valuation Gap to Peers -- Market Talk

14 янв. 2026 г., 23:32 UTC

Обсуждения рынка

Gold Declines on Likely Technical Correction, Possible Profit-Taking -- Market Talk

14 янв. 2026 г., 22:56 UTC

Приобретения, слияния, поглощения

Soho House Amends Rollover and Support Agreements With Broad Street Principal Investments and Others

14 янв. 2026 г., 22:53 UTC

Приобретения, слияния, поглощения

Soho House: Apollo Global Management and Goldman Sachs Asset Management Amend Debt Commitment

14 янв. 2026 г., 22:17 UTC

Обсуждения рынка

Global Equities Roundup: Market Talk

14 янв. 2026 г., 22:17 UTC

Обсуждения рынка

WiseTech's Revenue Growth Drivers Attract Scrutiny -- Market Talk

14 янв. 2026 г., 22:09 UTC

Отчет

CITIC Securities: Uptrend in China Capital Markets Supported Results >600030.SH

14 янв. 2026 г., 22:08 UTC

Отчет

CITIC Securities 2025 Oper Rev CNY74.83B Vs. CNY58.12B >600030.SH

14 янв. 2026 г., 22:08 UTC

Отчет

CITIC Securities 2025 Net CNY30.05B Vs. Net CNY21.57B >600030.SH

14 янв. 2026 г., 21:53 UTC

Приобретения, слияния, поглощения

WuXi XDC Expects 2025 Net to Increase Over 38% on Year

14 янв. 2026 г., 21:53 UTC

Приобретения, слияния, поглощения

WuXi XDC Expects 2025 Revenue to Increase More Than 45% on Year

14 янв. 2026 г., 21:52 UTC

Приобретения, слияния, поглощения

WuXi XDC Announces Positive Profit Alert for 2025

14 янв. 2026 г., 21:51 UTC

Приобретения, слияния, поглощения

Citigroup Acting as Financial Advisor to WuXi XDC

14 янв. 2026 г., 21:51 UTC

Приобретения, слияния, поглощения

WuXi XDC: Aims to Keep Listing Status of BioDlink

14 янв. 2026 г., 21:51 UTC

Приобретения, слияния, поглощения

WuXi XDC: Company to Finance BioDlink Shares Acquisition via Internal Resources

14 янв. 2026 г., 21:50 UTC

Обсуждения рынка
Отчет

Financial Services Roundup: Market Talk

14 янв. 2026 г., 21:50 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

14 янв. 2026 г., 21:49 UTC

Приобретения, слияния, поглощения

WuXi XDC: BioDlink Offer to Cost HK$2.79B

14 янв. 2026 г., 21:48 UTC

Приобретения, слияния, поглощения

WuXi XDC Offers to Pay HK$4.00 for Each BioDlink International Share

14 янв. 2026 г., 21:48 UTC

Приобретения, слияния, поглощения

WuXi XDC Makes Cash Offer for BioDlink International

14 янв. 2026 г., 21:13 UTC

Обсуждения рынка

Oil Retreats Late After Trump Comments on Iran -- Market Talk

14 янв. 2026 г., 20:30 UTC

Обсуждения рынка
Отчет

Danaher's Preliminary 4Q Seen as Promising -- Market Talk

14 янв. 2026 г., 20:13 UTC

Обсуждения рынка

U.S. Natural Gas Futures Sink Ahead of Storage Report -- Market Talk

14 янв. 2026 г., 20:08 UTC

Обсуждения рынка

Oil Futures Extend Rally on Iran Tensions -- Market Talk

14 янв. 2026 г., 19:33 UTC

Обсуждения рынка

Nutrien Seen as Winner in Tighter 2026 Potash Market, Higher Prices -- Market Talk

14 янв. 2026 г., 19:06 UTC

Обсуждения рынка
Отчет

Wells Fargo Says Customers, Economy Remain Resilient -- Market Talk

Сравнение c конкурентами

Изменение цены

Smith & Nephew PLC ADR Прогноз

Целевая цена

By TipRanks

6.15% рост

Прогноз на 12 месяцев

Средняя 35.75 USD  6.15%

Максимум 37.5 USD

Минимум 34 USD

Основано на мнении 2 аналитиков Wall Street, спрогнозировавших целевые цены для Smith & Nephew PLC ADR на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Нейтрально

2 ratings

0

Покупка

2

Удержание

0

Продажа

Техническая оценка

By Trading Central

26.64 / 28.37Поддержка и Сопротивление

Краткосрочная

Bullish Evidence

Среднесрочная

Bullish Evidence

Долгосрочная

Bullish Evidence

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Smith & Nephew PLC ADR

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
help-icon Live chat